Buy SS-31 50 mg + bacteriostatic water
€120.29
SS-31 (elamipretide), 50 mg, with bacteriostatic water, is a synthetic tetrapeptide format for mitochondrial, membrane-binding and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to lot-specific purity and identity verification.
Buy SS-31 (Elamipretide), 50 mg + Bacteriostatic Water, for Advanced Laboratory Research in Europe
SS-31, also known as elamipretide or MTP-131, is a synthetic aromatic-cationic tetrapeptide used as a laboratory reagent in mitochondrial-membrane research, peptide analytics and controlled in vitro investigations. The commonly reported free-base sequence is H-D-Arg-Dmt-Lys-Phe-NH₂, where Dmt denotes 2′,6′-dimethyl-L-tyrosine. Its reported free-base formula is C₃₂H₄₉N₉O₅, with an average molecular mass near 639.8 Da. Pharma Research .eu presents this 50 mg format with bacteriostatic water for qualified European laboratory teams.peptalabs+2
Uncompromising Purity and Analytical Characterisation
SS-31 should be specified as the C-terminally amidated tetrapeptide:
H-D-Arg-Dmt-Lys-Phe-NH₂
The D-arginine residue, Dmt residue and C-terminal amide are structurally important. They distinguish SS-31 from related linear peptides and from other Szeto–Schiller compounds. The supplier should state whether the material is supplied as the free base, hydrochloride salt or another salt form because the salt can change the reported molecular mass and formula.
For laboratory procurement, the appropriate target is ≥99.0% purity by RP-HPLC, subject to confirmation by the actual batch-specific certificate of analysis. Some research listings report purity above 99%, while other products use lower specifications; the lot-specific chromatogram should therefore control acceptance.peptalabs+2
A complete CoA should include:
-
RP-HPLC purity percentage, analytical method and chromatogram.
-
LC-MS, ESI-MS or high-resolution MS identity confirmation.
-
Sequence, stereochemical configuration and C-terminal amidation.
-
Dmt identity and nomenclature.
-
Free-base, hydrochloride or other salt-form designation.
-
Molecular formula and molecular mass for the supplied form.
-
Visual appearance of the lyophilised material.
-
Residual-solvent results from synthesis and purification.
-
Water or residual-moisture content, where measured.
-
Heavy-metal or elemental-impurity results where included in the quality programme.
-
Lot number, manufacture date, retest date and storage conditions.
For the free base, public references report formula C₃₂H₄₉N₉O₅, exact mass approximately 639.39 Da and average molecular mass near 639.8 g/mol. An HCl salt has a different reported mass, so a product page must not transfer free-base specifications to a salt-form product without documentation.peptalabs+1
SS-31 is normally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but it cannot establish peptide identity or purity. Analytical release should combine visual assessment with chromatographic purity and mass-spectral confirmation.
High purity is essential for mitochondrial-membrane studies because related cyclic or linear impurities, incorrect stereoisomers, incomplete amidation, oxidation products and residual synthesis materials may alter charge, hydrophobicity, membrane association and assay response. Lower-grade material may be unsuitable for quantitative LC-MS, receptor or membrane-binding studies, or publication-quality comparisons.
Bacteriostatic water is a separate reagent and should have its own label, expiry date, preservative information and documentation. Preservatives may influence chromatography, ionisation, adsorption, osmolality or cellular assay performance.
Principal Laboratory Applications and Research Methodologies
SS-31 is suitable for controlled laboratory research involving mitochondrial biophysics, membrane-associated peptide behaviour, analytical characterisation and in vitro cellular models. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.
Peptide identity and impurity profiling. SS-31 can be used to develop RP-HPLC and LC-MS methods for intact-mass confirmation, retention-time assignment and impurity detection. The method should be capable of distinguishing the principal peptide from incorrect stereochemical forms, incompletely modified species and oxidation products.
Mitochondrial-membrane and cardiolipin-binding models. The peptide may be investigated in defined cell-free systems examining interactions with model membranes or cardiolipin-containing lipid assemblies. Appropriate controls should account for peptide concentration, ionic strength, pH, membrane composition and non-specific adsorption.
In vitro cellular bioenergetics research. A verified SS-31 lot may be included in controlled cellular models examining mitochondrial membrane potential, oxidative-stress markers, respiration-related parameters or other validated bioenergetic read-outs. Vehicle controls, untreated controls and independent confirmation of peptide integrity should be included.
Analytical reference and system-suitability work. A documented lot may support instrument checks, calibration development, retention-time comparison and sample-preparation studies. Unless formally certified under a recognised reference-material standard, it should be described as a research reference material or analytical reagent rather than a certified reference material.
The 50 mg quantity corresponds to approximately 78.1 µmol using the reported free-base average molecular mass of 639.8 g/mol. No final molar concentration should be stated because the volume of bacteriostatic water was not specified. The actual concentration depends on the final volume, purity, salt form, water content and validated preparation procedure.
The bacteriostatic-water component should be assessed for compatibility with the intended workflow. Preservatives can influence LC-MS background, membrane assays and cell-based read-outs. Laboratories should use solvent blanks and matrix controls, and should confirm that the selected medium does not independently alter the experimental endpoint.
Compound Stability, Optimal Storage, and Safe Handling Protocols
SS-31 should remain sealed in its lyophilised form until required for a validated laboratory procedure. Research-product references commonly recommend storing the dry peptide at approximately −20°C, protected from light and moisture. Prepared solutions are generally handled cold, but the permissible storage duration depends on solvent, concentration, container, pH and the supplier’s stability data.halobuilt+2
Recommended controls include:
-
Store unopened lyophilised SS-31 at −20°C unless the CoA specifies otherwise.
-
Consider −80°C for extended archival storage when supported by the laboratory stability programme.
-
Keep the vial tightly closed, dry and protected from direct light.
-
Allow a sealed vial to reach room temperature before opening to minimise condensation.
-
Use low-binding tubes where adsorption could affect recovery.
-
Prepare aliquots when repeated vial access is expected.
-
Store short-term aqueous solutions at 2–8°C only when validated.
-
Use frozen aliquots for longer-term solution storage where supported by stability data.
-
Avoid repeated freeze–thaw cycles.
-
Record solvent, concentration, preparation date, operator and storage history.
The aromatic-cationic structure of SS-31 can influence adsorption, membrane association and apparent recovery. These properties should be considered during container selection, filtration, dilution and sample preparation. A solution that appears clear may still have experienced concentration loss through surface binding.
Reconstitution should be performed using a validated laboratory procedure. Add the selected aqueous reagent gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation unless the procedure has been shown to preserve recovery and integrity. For sensitive assays, confirm concentration and chromatographic integrity after preparation and storage.
Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.
Technical Specifications and Molecular Attributes
| Attribute | Specification |
|---|---|
| Product | SS-31 (elamipretide), 50 mg, supplied with bacteriostatic water |
| Synonyms | Elamipretide, MTP-131, Bendavia |
| Sequence | H-D-Arg-Dmt-Lys-Phe-NH₂ |
| Residue count | 4 amino acids |
| Dmt designation | 2′,6′-Dimethyl-L-tyrosine |
| IUPAC name | Full systematic name should be confirmed on the CoA; sequence notation is preferred for procurement |
| CAS Registry Number | 736992-21-5 is widely reported for the free base; verify the supplied salt form |
| Molecular formula, free base | C₃₂H₄₉N₉O₅ |
| Average molecular mass, free base | Approximately 639.8 g/mol |
| Exact mass, free base | Approximately 639.39 Da |
| Physical state and colour | Lyophilised white to off-white powder |
| Solubility profile | Aqueous reconstitution may be feasible; solvent and buffer compatibility require assay-specific validation |
| Typical purity | Proposed target ≥99.0% by RP-HPLC; verify the lot-specific result |
| Identity testing | LC-MS, ESI-MS or high-resolution MS |
| Companion reagent | Bacteriostatic water; volume and formulation should be confirmed on the packaging |
| Long-term storage | Typically −20°C, sealed and protected from light and moisture |
The sequence, free-base formula, CAS number and molecular mass are consistently reported by several chemistry and research references. However, salt-form products may have different specifications, and one commercial record reports a substantially different formula and CAS number; the CoA must therefore control the final technical table.peptalabs+2
Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents
Pharma Research .eu can position SS-31 as a documented European laboratory reagent for analytical chemists, biochemists, pharmacologists and laboratory managers requiring a defined mitochondria-targeted peptide. The product file should include a batch-specific CoA, SDS, sequence designation, stereochemical information, purity result, identity data, salt-form information and storage instructions.
Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims regarding discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.
A quality-focused supplier should be able to discuss:
-
D-Arg, Dmt, Lys and Phe stereochemical configuration.
-
Free-base versus hydrochloride or other salt form.
-
RP-HPLC purity and LC-MS identity testing.
-
Residual solvents, moisture and elemental-impurity reporting.
-
Packaging configuration and container-closure integrity.
-
Compatibility of bacteriostatic water with mitochondrial and analytical workflows.
-
Storage, transport and documentation requirements.
Pharma Research .eu should therefore be described as a potential European source for research-grade SS-31, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.


Reviews
There are no reviews yet.